menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Lee Merrill Jampol, MD
Lee Merrill Jampol, MD
  • Professor of Ophthalmology
  • Feinberg School of Medicine
  • Northwestern University
I am a full-time faculty member at Northwestern University. My career has focused on clinical trials, inflammatory diseases of the retina, cystoid macular edema, pharmacology of the retina and central serous chorioretinopathy. I have also been extensively involved in clinical and research work on diabetic retinopathy and age related macular degeneration. Since 1985, when I became a member of the Data Monitoring Committee of the Macular Photocoagulation Study, I have been extensively involved in data monitoring and planning of clinical trials. I have been on the data monitoring committee of the MPS, SST, SCORE and the DRCR. I have been involved with the DRCR since its conception as an active member of the data monitoring committee, helping to monitor data but also to plan the clinical trials. I was Chair of the Diabetic Retinopathy Clinical Research Network (DRCR.net), a U-10 from the NIH supporting research on diabetic retinopathy from 2013-2017 and am presently Chair emeritus. I have also served on the external advisory committee of the Latino Eye Study and the Beaver Dam Study.

Clinically, I remain active particularly in the area of white spot syndromes of the retina. Administratively, I have been president of the American Ophthalmological Society, trustee and vice president of ARVO, president of the Chicago Ophthalmological Society. I was Chairman of the Department of Ophthalmology at Northwestern University from 1983-2010.

I have also been involved in data monitoring for pharmaceutical companies, including the treatment of uveitis, age related macular degeneration and diabetic retinopathy. In view of conflict of interest concerns, I am presently only a consultant to Stem Cell Organization for their studies of age related macular degeneration.
Schedule29 Mar 2024